Bone Marrow Transplant Risks for the Donor: What It Means, What to Expect and When to See a Specialist

The call usually comes years after the cheek swab. Someone joined a registry at a campus drive or a workplace event, half-forgot about it, and then a coordinator is on the phone saying a stranger with leukemia matches their tissue type. The first reaction is almost always the same: a rush of purpose, followed within the hour by a quieter question. What will this do to me?

That question deserves a straight answer rather than reassurance. Bone marrow donation has a reputation built partly on old television dramas, in which a donor is wheeled away and wakes up hollowed out. The modern reality is less cinematic. Most donors never see an operating room at all, and those who do are typically home by the next morning.

Still, low risk is not zero risk, and a donor who understands the mechanics, the sore spots and the rare complications makes a better decision, and a calmer one, than a donor who simply trusts the pamphlet.

Is donating bone marrow safe for the donor?

Yes, for the healthy adults who pass screening, donation is a low-risk procedure with a decades-long safety record. The key phrase is for the healthy adults who pass screening. Registries and transplant teams evaluate donors precisely because the safest donor is one whose heart, lungs, blood counts and medical history give no reason for concern. The Mayo Clinic describes the risks to marrow donors as low, with complications that are usually minor and temporary.

Two facts anchor that reassurance. First, the body treats donated marrow the way it treats donated blood: as something to replace. Stem cells left behind divide and refill the harvested space, and the NHS notes the marrow replaces itself within a few weeks. Second, unlike organ donation, nothing permanent is removed. You do not live with one fewer kidney or a shortened liver. You live with a bruise on your lower back, or a few days of aching bones, and then with nothing at all.

What the evidence does not support is the claim that donation is entirely without risk. Any general anesthetic carries a small chance of reaction. Any procedure that draws blood or punctures bone carries a small chance of bleeding or infection. Large registries track donors for years after donation specifically so that rare events are counted rather than assumed away. Honesty about those rare events is what makes the overall reassurance credible.

Marrow harvest or stem cells from the blood: which one will I be asked for?

Donors are often surprised to learn there are two very different procedures, and that the recipient’s transplant team, not the donor, usually decides which one is needed. Both deliver the same thing: blood-forming stem cells capable of rebuilding a patient’s marrow after theirs has been wiped out by chemotherapy or radiation.

Feature	Marrow harvest	Blood stem-cell (apheresis) donation
Where cells come from	Liquid marrow drawn from the back of the pelvic bone	Bloodstream, after growth-factor injections move stem cells out of the marrow
Anesthesia	General or regional anesthetic	None
Setting	Hospital operating room	Outpatient apheresis unit, similar to a blood-donation chair
Time on the day	About one to two hours (Mayo Clinic)	Several hours, sometimes repeated the next day (NHS)
Most common after-effects	Lower-back and hip soreness, fatigue, bruising	Bone and muscle aches, headache, fatigue before and during collection
Typical recovery	A few days to a couple of weeks	Symptoms usually settle within days of the last injection

The blood route now accounts for the majority of adult unrelated donations, which is why the fear of surgery is so often misplaced. Marrow harvest is still requested in particular situations, including many transplants for children, where the recipient’s team believes marrow offers a better balance of benefits for that patient. A donor is entitled to ask why one method was chosen, and a good coordinator will explain.

Do bone marrow transplants hurt the donor?

Not during the procedure itself, and afterward the honest word is sore rather than painful. A marrow harvest happens under anesthesia, so the donor feels nothing while needles are inserted into the pelvic bone. The discomfort arrives later, once the anesthetic wears off, and it concentrates in the lower back and hips. Donors commonly compare it to a hard fall on ice or the deep ache after an unusually tough workout. Walking, sitting for long stretches and climbing stairs can be uncomfortable for a few days.

The Mayo Clinic lists tiredness, weakness and trouble walking for a few days among the expected after-effects, along with soreness at the needle sites. Over-the-counter pain relief, chosen with the donation team’s guidance, is usually enough. The soreness does not linger for months; most donors describe it fading over one to two weeks.

Blood stem-cell donation produces a different kind of discomfort, and it comes before the collection rather than after. The growth-factor injections given in the days leading up to apheresis push the marrow into overdrive, and the result is often a flu-like ache in the long bones, the pelvis and the lower back, sometimes with headache and fatigue. Once the injections stop and the collection is done, those symptoms typically lift within a day or two. The collection itself is not painful, though needles in both arms for several hours can feel tedious.

What happens during a marrow harvest, step by step

The procedure is far less invasive than the word surgery suggests. No incision is made. Instead, the donor lies face down under general or regional anesthesia while the physician inserts a hollow needle through the skin into the back of the pelvic bone, the flat, wide iliac crest that sits just above each buttock. This spot is chosen because it holds a large reservoir of marrow close to the skin’s surface, away from major nerves and organs.

Liquid marrow is drawn out in repeated small pulls, the needle repositioned a few millimeters each time, through a small number of skin punctures. The Mayo Clinic puts the whole procedure at around one to two hours. Only a fraction of the body’s total marrow is taken; the rest continues working, and the harvested volume is replenished over the following weeks.

Afterward, the donor moves to recovery, where nurses monitor blood pressure and check the puncture sites, which are covered with pressure dressings. Because the harvested marrow carries red blood cells with it, hemoglobin dips temporarily. Some donors feel lightheaded when they first stand. The Mayo Clinic notes most donors go home the same day or the following morning, and MedlinePlus describes the donor experience as generally uncomplicated.

A responsible team will also give the donor written instructions covering wound care, warning signs and a follow-up contact, then check in by phone in the days that follow.

How the blood stem-cell route works, and what those injections actually do

Under normal conditions very few blood-forming stem cells circulate in the bloodstream; they stay anchored in the marrow. Apheresis donation depends on coaxing them out, and this is where the growth-factor injections come in.

The medication is a laboratory-made version of a signaling protein the body already produces. Its mechanism is straightforward: it tells the marrow to ramp up production of white blood cells and, as a side effect of that surge, loosens the stem cells’ grip so they spill into circulation. Donors receive these injections daily for a few days before collection, typically four to five according to NHS guidance, with the schedule set by the donation team. The dose and product are the prescribing clinician’s decision and are not something a donor needs to research independently.

On collection day, a needle in each arm connects the donor to an apheresis machine. Blood flows out of one arm, spins through a centrifuge that separates stem cells by density, and returns through the other arm minus those cells. The NHS notes a session usually lasts several hours, and a second day may be needed if the first yields too few cells.

The most common in-chair sensation is tingling around the lips or fingertips. That comes from the anticoagulant that keeps blood from clotting in the tubing; it temporarily binds calcium in the bloodstream, and nurses can counter it easily. Feeling cold is also common, hence the blankets.

How long do side effects last after donating?

The answer differs by method, but both routes share a reassuring pattern: symptoms peak early and fade fast. For marrow donors, the Mayo Clinic describes soreness, tiredness and difficulty walking for a few days, with most people feeling back to normal within a couple of weeks. The lower-back ache is usually worst on days one and two, then steadily improves. Bruising at the puncture sites can take longer to disappear, but by then it no longer hurts.

Blood stem-cell donors typically feel worst on the day before collection, when the growth-factor effect is at its height. The bone and muscle aches, headache and fatigue reported by the Mayo Clinic tend to resolve within a day or two of the last injection because the medication clears quickly once stopped. Some donors also notice their spleen area, under the left ribs, feels tender; this is expected to settle as blood counts return to baseline.

What the NHS emphasizes for both groups is the temporary dip in blood counts. Marrow donors lose some red cells with the harvest and may feel tired or short of breath on stairs for a week or two while iron stores rebuild. Apheresis donors may see a brief drop in platelets. Neither dip requires treatment in the typical donor, but both explain why fatigue can outlast the aching.

If a symptom is trending the wrong way, worse on day five than on day two, that is a reason to call rather than wait it out.

Rare but serious donor risks: what the evidence actually shows

Any honest guide has to name the serious risks, and then be equally honest about how uncommon they are. For marrow harvest, the meaningful risks are those of any procedure under general anesthesia: an allergic or breathing reaction to the anesthetic, bleeding at the harvest site, and infection introduced through the skin punctures. The Mayo Clinic lists anesthesia reaction as the main serious risk and characterizes complications overall as rare. Nerve or bone injury from the needle is possible in theory, but the pelvic crest is chosen precisely because it puts thick bone between the needle and anything critical.

For apheresis donors, the serious concerns are tied to the growth-factor injections rather than the collection. Because the medication enlarges the spleen as it fills with newly produced white cells, there have been extremely rare reports of splenic rupture. This is why donors are told to avoid contact sports and heavy lifting during the injection period and to report sudden left-sided or shoulder-tip pain immediately. Blood clots and, exceptionally, cardiovascular events have been reported in older or predisposed donors, which is one reason screening is stringent.

Large registries follow donors for years after donation to detect long-term harms. Their published follow-up, summarized by transplant guidance from the NHS and Mayo Clinic, has not established an increased risk of blood cancers or other lasting disease among donors. Absence of a proven signal is not the same as proof of zero risk, and those surveillance programs continue for that reason. Donors should read that ongoing vigilance as a strength of the system, not a red flag.

Why can't people over 60 donate bone marrow?

The age limits set by donor registries have less to do with protecting older donors, though that matters, and more to do with what happens to the recipient. Transplant outcome data consistently favors cells from younger donors, which is why most registries prioritize recruiting people in their late teens through their thirties and stop calling registered donors around age 60, a policy that varies by country and program.

The biology behind this is well described. Stem cells accumulate small genetic changes with age, and an older immune system repopulating a recipient’s body appears to carry a higher risk of complications such as graft-versus-host disease, in which donated immune cells attack the recipient’s tissues. Younger cells also tend to engraft more robustly. When a transplant physician has several matched donors to choose from, the younger one is usually selected on those grounds alone.

Donor safety is the second reason. The likelihood of high blood pressure, heart disease, diabetes and other conditions rises with age, and each of those raises the risk of a general anesthetic or of clotting complications during growth-factor treatment. A registry cannot examine every member, so an age cutoff functions as a blunt but practical safety margin.

Family donation works differently. A healthy sibling in their sixties may still donate to a brother or sister if the transplant team’s individual assessment supports it, because a matched relative is often a better option than no matched donor at all.

Who gets screened out, and why the rules protect both people

Being matched is not the same as being cleared. Between the phone call and the donation lies a medical work-up that some potential donors find surprisingly thorough, and occasionally disappointing when it ends in a no.

The screening exists to answer two questions. Is this donor likely to tolerate anesthesia or growth-factor injections without harm? And is there anything in this donor’s blood or history that could be passed to a recipient whose immune system will be defenseless for weeks? The second question explains why donors are tested for bloodborne infections, asked detailed travel and exposure questions and, in some programs, temporarily deferred after recent tattoos or piercings, just as blood donors are.

Conditions that commonly rule a donor out include a history of blood cancers or autoimmune disease affecting the blood, uncontrolled heart or lung disease, bleeding disorders, active infection and certain chronic infections. Pregnancy defers donation until after delivery. Being significantly above a healthy weight range for one’s height can complicate anesthesia and needle access, and programs assess this individually rather than by appearance. MedlinePlus and the NHS both describe donor testing for infections and tissue typing as standard.

A donor who is declined for a medical reason often learns something useful about their own health in the process, sometimes for the first time. Coordinators are trained to explain the reason and to direct the person to their own physician for follow-up.

Recovery timeline: getting back to work, exercise and travel

Planning around donation is easier when the timeline is laid out plainly, and it is shorter than most people expect.

For a marrow harvest, the Mayo Clinic notes most donors leave the hospital the same day or next morning. Desk-based work is often possible within a few days, though sitting for long periods can be uncomfortable at first. Physically demanding jobs and structured exercise usually wait one to two weeks, until the back and hip soreness has settled. Many donors describe a fatigue that outlasts the pain by a week or so, linked to the temporary drop in red cells; iron-rich meals and patience help.

For blood stem-cell donation, the demanding stretch is the week of injections and collection. Donors are advised against contact sports and heavy lifting while the growth factor is active because of the small spleen risk. Once collection is complete, most people return to normal activity within a day or two. Arm bruising from the needles fades over a week.

Two practical points deserve emphasis. Donors should not drive themselves home after general anesthesia, and they should arrange a full day off around any apheresis session, since collection may run for hours and occasionally into a second day. Most programs also ask donors to remain reachable for a short period afterward, in case the recipient’s team needs additional cells or the donor develops a symptom worth checking.

Does donating bone marrow affect long-term health or fertility?

The evidence to date does not show lasting harm to donors, and this is one of the most-studied questions in transplant medicine because registries have a duty to their volunteers.

Fertility is a frequent worry, partly because people conflate donation with the recipient’s chemotherapy. The growth-factor injections act on blood-forming cells and are cleared from the body within days; they do not target the ovaries or testes, and there is no established mechanism by which a single short course would affect eggs or sperm. Marrow harvest removes cells from the pelvic bone, not from reproductive organs. Neither procedure involves radiation.

The other common fear is that donation might trigger a blood cancer in the donor, given that the growth factor stimulates white-cell production. Long-term registry follow-up, summarized in the Mayo Clinic and NHS guidance, has not found an increased rate of leukemia or related cancers among donors compared with the general population. Surveillance continues, and any donor who later develops a blood disorder is asked to report it so that the data stays honest.

Marrow itself does not run out. The harvested volume is a fraction of the total, and the NHS describes full replacement within a few weeks. A person who donates once can, if called again, be assessed for a second donation.

Where evidence is thin is in donors with pre-existing conditions that were borderline at screening, which is exactly why those donors are evaluated case by case rather than waved through.

What are the odds of surviving a bone marrow transplant, and why the donor should not carry that number

Donors often ask this on the recipient’s behalf, sometimes with a quiet fear that a poor outcome will somehow be their fault. Two things need saying.

First, survival after a transplant varies enormously and no single figure is meaningful. MedlinePlus explains that outcomes depend on the underlying disease and its stage, the recipient’s age and general health, how closely the donor matches, the intensity of the chemotherapy or radiation used to prepare the recipient, and complications such as infection and graft-versus-host disease. A young patient in remission receiving cells from a fully matched sibling is in a very different position from an older patient with advanced disease. Any percentage a donor finds online is an average across thousands of unlike situations.

Second, the donor’s contribution is a necessary condition, not a determinant. Cell dose is checked before infusion; if a collection falls short, the team asks for more rather than proceeding. Beyond providing healthy cells and honest screening answers, the donor influences nothing about how the transplant unfolds. Rejection, relapse and infection are properties of the disease and the recipient’s body, not of the gift.

Many programs allow anonymous contact between donor and recipient after a waiting period, and some allow identities to be shared if both agree. Donors should decide in advance how much they want to know. It is entirely reasonable to donate and never learn the outcome, and just as reasonable to want the letter.

The emotional side: family pressure, anonymity and the right to say no

The medical risks of donation are small. The emotional weight is not, and it is rarely discussed in the clinical paperwork.

Related donors face the sharpest version. When a sibling is the only match, the family’s hope concentrates on one person, and the word choice can feel theoretical. Transplant teams recognize this, which is why donor evaluation is typically handled by a clinician separate from the recipient’s team, with a private conversation in which the potential donor can raise doubts, fears or medical history without a parent or spouse in the room. A donor who has real reservations, medical or personal, is entitled to decline, and the team will communicate that in a way that protects the relationship. Nobody is obligated to undergo anesthesia for another person, even a sibling.

Unrelated donors face a different strain: waiting. Weeks can pass between the initial match call and a decision to proceed, and the donation may be postponed or canceled if the recipient’s condition changes. Coordinators describe donors who reorganized work and childcare only to be stood down, and the disappointment is real even when the reason is good news for the patient.

Guilt can surface later if the recipient does poorly. Registries offer support conversations for donors, and the NHS and MedlinePlus both frame donation as one component of a treatment whose outcome depends on many factors beyond the cells themselves. Feeling proud of a donation and grieving a bad outcome are not contradictions.

When to see a specialist after donating: red flags that need a same-day call

Most donors need nothing beyond the scheduled follow-up call. A small number develop symptoms that should be reported the same day, and every donation program provides a direct number for exactly this purpose. Use it rather than waiting for a routine appointment.

Call promptly if you notice any of the following:

• Fever, chills, or spreading redness, warmth or pus at a needle site, which can signal infection in the skin or deeper tissue.
• Bleeding from a puncture site that soaks through a dressing or does not stop with firm pressure.
• Sudden, severe pain under the left ribs or in the left shoulder tip during or shortly after growth-factor injections, which can indicate a problem with the spleen and needs urgent assessment.
• Shortness of breath, chest pain, or a swollen, painful calf, which can point to a blood clot.
• Numbness, weakness or shooting pain down a leg that persists beyond the first day or two after marrow harvest.
• Fainting, persistent dizziness or a racing heartbeat when standing, beyond the mild lightheadedness expected on the first day.

Seek emergency care immediately, rather than phoning, for chest pain, difficulty breathing, sudden severe abdominal pain or any sign of a severe allergic reaction such as facial swelling or difficulty swallowing.

Soreness that is easing, fatigue that is gradually lifting and bruising that is changing color are the normal course and do not require a specialist. The pattern to watch is direction: symptoms that worsen after day three, or new symptoms that appear once you were already feeling better, warrant a conversation with the donation team or your own physician.

Frequently asked questions

Is donating bone marrow safe for the donor?

For healthy adults who pass screening, yes; it is considered a low-risk procedure. The most common effects are temporary soreness in the lower back and hips after a marrow harvest, or bone aches and headache during growth-factor injections before a blood stem-cell collection. Serious complications such as anesthesia reactions, significant bleeding or infection are rare, and registries follow donors for years to confirm long-term safety.

Do bone marrow transplants hurt the donor?

Not during the procedure, because marrow harvest is done under anesthesia and apheresis involves only needles in the arms. Afterward, marrow donors typically describe a deep ache in the lower back and hips, similar to a hard fall, that eases over one to two weeks. Blood stem-cell donors feel flu-like bone aches in the days before collection, which usually resolve within a day or two of stopping the injections.

Why can't people over 60 donate bone marrow?

Registries set upper age limits mainly because transplant outcomes are better with cells from younger donors, whose stem cells carry fewer age-related genetic changes and are associated with lower rates of complications such as graft-versus-host disease. Donor safety is the second reason, since heart disease and other conditions that raise anesthesia and clotting risk become more common with age. Related donors over 60 may still be assessed individually.

What are the odds of surviving a bone marrow transplant?

There is no single meaningful figure, because survival depends heavily on the disease being treated, its stage, the recipient’s age and health, how closely the donor matches and complications such as infection or graft-versus-host disease. A young patient in remission with a fully matched donor has a very different outlook from an older patient with advanced disease. The recipient’s own transplant team is the right source for a personalized estimate.

How long does it take to recover from donating bone marrow?

Most marrow donors feel sore and tired for a few days and are back to normal activity within a couple of weeks, with desk work often possible sooner. Blood stem-cell donors usually recover within a day or two after collection, once the growth-factor effects wear off. Fatigue can outlast the aching by a week or so because blood counts take time to rebuild after either method.

Will donating bone marrow affect my fertility?

There is no established mechanism by which either donation method affects fertility. Marrow is taken from the pelvic bone, not the reproductive organs, and no radiation is involved. The growth-factor injections act on blood-forming cells and clear from the body within days. Long-term donor follow-up has not identified fertility problems linked to donation, and this remains a monitored question in registry surveillance.

Can donating bone marrow cause cancer later?

Current evidence does not show it. Because growth-factor injections stimulate white-cell production, researchers have specifically tracked donors for later blood cancers, and long-term follow-up has not found rates higher than the general population. Registries continue this surveillance and ask donors to report any later blood disorders, which is how the reassurance stays grounded in data rather than assumption.

What is the difference between marrow donation and stem cell donation?

Marrow donation draws liquid marrow from the back of the pelvic bone under anesthesia in an operating room. Blood stem-cell donation uses several days of growth-factor injections to move stem cells into the bloodstream, then collects them through an apheresis machine over a few hours with no anesthesia. Both provide the same blood-forming cells; the recipient’s transplant team decides which method suits the patient.

How much bone marrow is taken and does it grow back?

Only a fraction of the body’s total marrow is harvested, and the remaining stem cells divide to refill the space. The NHS describes marrow as replacing itself within a few weeks. Because red blood cells are removed along with the marrow, donors may feel tired for a week or two while iron stores recover, but nothing is permanently lost.

Can I refuse to donate after being matched?

Yes. Donation is voluntary at every stage, including for family members, and no one is obligated to undergo anesthesia or injections for another person. Transplant teams typically assign related donors a separate clinician so concerns can be raised privately. The one caution is timing: once the recipient has started the chemotherapy that destroys their own marrow, withdrawing becomes life-threatening for them, so doubts should be voiced early.

References

• NHS — Stem cell and bone marrow transplants: What happens
• NHS — Stem cell and bone marrow transplants: Risks
• MedlinePlus — Bone marrow transplant

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.